Non-PVC IV Bags Market Size To Reach $3.97 Billion By 2030

Non-PVC IV Bags Market Growth & Trends

The global non-PVC IV bags market size is expected to reach USD 3.97 billion by 2030, exhibiting a CAGR of 11.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.  Demand for non-PVC substitutes is expected to grow in response to increasing global demand for nontoxic medical packaging and stringent legislation banning the use of polyvinyl chloride (PVC). Significant research and development for new alternatives is also expected to drive the global non-PVC IV bags market over the forecast period.

Non-PVC IV bags are majorly used for parenteral nutrition and chemotherapy. With the advent of different varieties of substitutes such as EVA and polypropylene, PVC packaging is likely to be replaced by non-PVC substitutions such as polypropylene and EVA. These materials might be utilized for several purposes, such as cold or frozen storage and custom mixtures. Thus, the wide applicability of non-PVC IV bags is expected to propel the non-PVC IV bags market growth over the forecast period.

In addition, stringent regulatory policies related to PVC IV bags have led to the increase in the use of non-PVC materials in the medical and non-medical industries. The global movement toward non-PVC materials provides tremendous growth prospects, drawing producers and investors to the sector. Non-PVC IV bags are becoming more common in parenteral nutrition services. Since the composition varies from patient to patient, they have a high demand for multi-chambered containers. With the introduction of tailored clinical solutions, the need for customized IV bag suppliers is expected to grow.

 Request a free sample copy or view report summary: Non-PVC IV Bags Market Report

Non-PVC IV Bags Market Report Highlights

• Single chamber bags segment accounted for the largest share of 63.62% in 2022. The high use of IV drips and other mixtures is a major factor that can be contributed to the huge share

• Ethylene vinyl acetate captured the largest share of around 33.62% in 2022 and this dominance is likely to continue over the estimated period. Higher protection and utility of its use in frozen mixtures, like blood banks, are expected to have a significant effect on segment development

• The liquid mixture segment held the largest market share of around 78.62% in 2022 owing to its increase in use across the globe

• North America dominated the market and is anticipated to lead throughout the forecast period. On the other hand, Asia Pacific is estimated to showcase the fastest growth, driven by factors such as the emergence of a large number of local companies and growing foreign direct investment

Non-PVC IV Bags Market Segmentation

Grand View Research has segmented the global non-PVC IV bags market report based on product, material, content, and region:

Non-PVC IV Bags Product Outlook (Revenue, USD Million, 2018 - 2030)

• Single Chamber

• Multi Chamber

Non-PVC IV Bags Material Outlook (Revenue, USD Million, 2018 - 2030)

• Ethylene Vinyle Acetate

• Polypropylene

• Copolyester Ether

• Others

Non-PVC IV Bags Content Outlook (Revenue, USD Million, 2018 - 2030)

• Frozen Mixture

• Liquid Mixture

Non-PVC IV Bags Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

• Asia-Pacific

  • Japan

  • China

• Latin America

  • Brazil

  • Mexico

• MEA

  • South Africa

  • Saudi Arabia

List of Key Players of Non-PVC IV Bags Market

• Baxter

• B. Braun Melsungen AG

• Pfizer, Inc. (Hospira)

• Fresenius Kabi AG

• JW Life Science

• RENOLIT

• PolyCine GmbH

• Sealed Air

• ANGIPLAST PVT. LTD

• Shanghai Solve Care Co Ltd.

• Kraton Corporation

• Jiangxi Sanxin Medtec Co., Ltd.